Atlas Trials

Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer

Clinical trial NCT03658434 · UNKNOWN

Trial details

NCT number
NCT03658434
Sponsor
Zealand University Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hormone-refractory Prostate Cancer
Start date
2018-08-01
Primary completion
2019-08-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.